본문 바로가기
bar_progress

Text Size

Close

[Breaking] Central Pharmaceutical Review Board: "AstraZeneca shows no safety issues in elderly yet... but low numbers mean statistical efficacy verification is pending"

[Breaking] Central Pharmaceutical Review Board: "AstraZeneca shows no safety issues in elderly yet... but low numbers mean statistical efficacy verification is pending"

[Asia Economy Reporter Lee Chunhee]


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top